Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-07

FDA Approved: RIVAROXABAN — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical's generic rivaroxaban under an original ANDA, for the same indications as the reference product (e.g., reducing stroke risk in n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)